Pharmacogenomics

Papers
(The H4-Index of Pharmacogenomics is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations37
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing27
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization26
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN1223
Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review22
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level22
Pharmacogenetics of Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Patients: the SUCLINGEN Study21
Rapid point of care testing: the next frontier in pharmacogenomics19
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison18
Integrated in a Systems Pharmacology Approach, Pharmacogenetics holds the Promise for Personalized Medicine in Neonates17
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications16
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report15
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations14
CYP2D6 Gene Resequencing in the Malagasy, a Population at the Crossroads between Asia and Africa: A Pilot Study13
0.84358501434326